Shengbiao Wan

5PUBLICATIONS
16CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMedical molecular engineering of nucleic acids and proteinsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 15, 2026
The New Delhi Metallo-β-lactamase-1 Covalent Inhibitors Derived from Cephalexin Effectively Reverse Meropenem Resistance.

|Nov 13, 2025
Structure-Directed Optimization of Ebselen Derivatives as Potent NDM-1 Inhibitors Reverses Meropenem Resistance.

Yan Guo, Chenyu Liu, Wandong Liu

|Nov 23, 2022
Correction to "Rational Design, Synthesis, and Biological Evaluation of Novel S1PR2 Antagonists for Reversing 5-FU-Resistance in Colorectal Cancer".

Dongdong Luo, Xiaochun Liu, Leilei Jiang

|Oct 21, 2022
Rational Design, Synthesis, and Biological Evaluation of Novel S1PR2 Antagonists for Reversing 5-FU-Resistance in Colorectal Cancer.

Dongdong Luo, Xiaochun Liu, Leilei Jiang

|Jun 18, 2020
SphK2 confers 5-fluorouracil resistance to colorectal cancer via upregulating H3K56ac-mediated DPD expression.

Yu-Hang Zhang, Wen-Na Shi, Shu-Hua Wu

Pageof 1

Frequent Collaborators

2 joint publications

Jiazhang Qiu

2 joint publications

Sheng Chen

2 joint publications

Xiaoyang Li

1 joint publications

Rilei Yu